Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New data presented from CARE-MS trials of alemtuzumab

Oct. 26, 2011

Qutenza shows efficacy in HIV-associated neuropathy

Oct. 26, 2011

Phase II studies assess NGR-hTNF in lung and ovarian cancer

Oct. 26, 2011

Phase III briakinumab data analyzed

Oct. 26, 2011

Phase III trial shows safety/tolerability of BG-12 in MS

Oct. 25, 2011

AMG-827 improves quality of life in patients with plaque psoriasis

Oct. 25, 2011

Phase II and III data presented on vorinostat

Oct. 25, 2011

Therapy benefits children with Tay-Sachs and Sandhoff's diseases / News in Context

Oct. 25, 2011

Study finds biomarkers of metastatic disease progression in prostate cancer

Oct. 25, 2011

First-in-human AVI-6003 trial advances

Oct. 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...